Abstract
Although low- and middle-income countries face countless challenges that high-income countries do not, they still manage to make funding available for biomedical research and discovery. These nations must conduct research preferentially based on original work and avoid replicative research.
Original language | English (US) |
---|---|
Pages (from-to) | 2668-2670 |
Number of pages | 3 |
Journal | Cancer |
Volume | 121 |
Issue number | 16 |
DOIs | |
State | Published - Aug 1 2015 |
Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Cancer Research
- Oncology
- Medicine(all)
Cite this
Emphasizing unique strengths and eliminating redundancy for research in low-income and middle-income countries : Lessons from a South American country. / Burotto, Mauricio; Prasad, Vinay.
In: Cancer, Vol. 121, No. 16, 01.08.2015, p. 2668-2670.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Emphasizing unique strengths and eliminating redundancy for research in low-income and middle-income countries
T2 - Lessons from a South American country
AU - Burotto, Mauricio
AU - Prasad, Vinay
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Although low- and middle-income countries face countless challenges that high-income countries do not, they still manage to make funding available for biomedical research and discovery. These nations must conduct research preferentially based on original work and avoid replicative research.
AB - Although low- and middle-income countries face countless challenges that high-income countries do not, they still manage to make funding available for biomedical research and discovery. These nations must conduct research preferentially based on original work and avoid replicative research.
UR - http://www.scopus.com/inward/record.url?scp=84938738141&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938738141&partnerID=8YFLogxK
U2 - 10.1002/cncr.29408
DO - 10.1002/cncr.29408
M3 - Article
C2 - 25903222
AN - SCOPUS:84938738141
VL - 121
SP - 2668
EP - 2670
JO - Cancer
JF - Cancer
SN - 0008-543X
IS - 16
ER -